CompanyGraph
What stands out
- Returns appear driven by leverage
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $19.73M, above the global median of $16.24M
- PositionReturn on equity is 41.9%, higher than 95% of its Health Information Services peers (median 0.5%)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
2.93%Above 5Y avg (2.06%)
Annual Rate
USD 0.64Paid quarterly
Payout Ratio
143.6%High
Consecutive Growth
1 yr
Paying Dividends
13 yr
Payback Period
37.0 yr
Last Ex-Dividend
Jun 26, 2026
Last Payment
Jul 10, 2026
The reported statements, read against the company's own industry.
What stands out
- Returns appear driven by leverage
Financials view
Market Capitalization
490.85MUSDvs all stocks (USD)
Trailing P/E
55.85xvs Health Information Services peers
Revenue (TTM)
138.64MUSDvs all stocks (USD)
Profit Margin
6.52%vs Health Information Services peers
Beta
0.3780xvs all stocks
52-Week Change
55.02%vs all stocks
Forward Annual Dividend Yield
2.93%vs all stocks
Market Capitalization
490.85MUSDvs all stocks (USD)
Enterprise Value
566.33MUSDvs all stocks (USD)
Trailing P/E
55.85xvs Health Information Services peers
Forward P/E
20.36xvs Health Information Services peers
PEG Ratio
-1.27xPrice to Sales (TTM)
3.54xvs Health Information Services peers
Price to Book (MRQ)
36.36xvs Health Information Services peers
Enterprise to Revenue
4.08xvs Health Information Services peers
Enterprise to EBITDA
16.37xvs Health Information Services peers
Gross Margin
60.79%vs Health Information Services peers
Profit Margin
6.52%vs Health Information Services peers
Operating Margin
16.00%vs Health Information Services peers
Return on Assets (TTM)
12.21%vs Health Information Services peers
Return on Equity (TTM)
41.86%vs Health Information Services peers
Revenue (TTM)
138.64MUSDvs all stocks (USD)
Revenue per Share (TTM)
6.28USDUpdated Jul 19, 2026Quarterly Revenue Growth
3.70%vs Health Information Services peers
Gross Profit (TTM)
85.68MUSDvs all stocks (USD)
EBITDA (TTM)
27.87MUSDvs all stocks (USD)
Net Income (TTM)
8.59MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-44.30%vs Health Information Services peers
Operating Cash Flow (TTM)
26.98MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
19.73MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.6400USDUpdated Jul 19, 2026Forward Annual Dividend Yield
2.93%vs all stocks
Trailing Annual Dividend Rate
0.6000USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
2.74%vs all stocks
5-Year Average Dividend Yield
2.06%vs all stocks
Payout Ratio
143.59%vs Health Information Services peers
Revenue
137.39MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
52.37MUSDFY2025 · Dec 31, 2025Gross Profit
85.02MUSDFY2025 · Dec 31, 2025Operating Income
22.59MUSDvs all stocks (USD)
Pre-tax Income
17.84MUSDFY2025 · Dec 31, 2025Income Tax Expense
6.25MUSDFY2025 · Dec 31, 2025Net Income
11.60MUSDFY2025 · Dec 31, 2025EBIT
22.61MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
30.23MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
54.80MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
111.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.76MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.5000USDFY2025 · Dec 31, 2025EPS (Diluted)
0.5000USDFY2025 · Dec 31, 2025Basic Shares Outstanding
22.38MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
22.38MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
11.60MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
308.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
24.63MUSDFY2025 · Dec 31, 2025Free Cash Flow
13.92MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.14MUSDFY2025 · Dec 31, 2025Interest Paid
4.49MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
11.60MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
7.62MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
2.63MUSDFY2025 · Dec 31, 2025Stock-based Compensation
3.31MUSDFY2025 · Dec 31, 2025Other Non-cash Items
243.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-53.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
170.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-895.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-10.71MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-10.71MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
84.68MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-68.44MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-20.18MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-10.98MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.06MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.97MUSDFY2025 · Dec 31, 2025Shares Outstanding
22.54MSharesUpdated Jul 19, 2026Float Shares
12.23MSharesUpdated Jul 19, 2026Shares Short
468.68KSharesUpdated Jul 19, 2026Short Ratio
2.71daysvs all stocks
Short % of Shares Outstanding
16.60%vs all stocks
% Held by Insiders
48.87%vs all stocks
% Held by Institutions
49.84%vs all stocks
Total Cash (MRQ)
2.55MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.1130USDUpdated Jul 19, 2026Total Debt (MRQ)
78.03MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
5.78xvs Health Information Services peers
Current Ratio (MRQ)
0.5190xvs Health Information Services peers
Book Value per Share (MRQ)
0.5990USDUpdated Jul 19, 2026Total Assets
134.88MUSDvs all stocks (USD)
Total Current Assets
20.21MUSDFY2025 · Dec 31, 2025Total Liabilities
120.89MUSDFY2025 · Dec 31, 2025Total Non-current Assets
114.67MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
84.27MUSDFY2025 · Dec 31, 2025Total Current Liabilities
36.62MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.14MUSDFY2025 · Dec 31, 2025Accounts Receivable
11.11MUSDFY2025 · Dec 31, 2025Accounts Payable
1.17MUSDFY2025 · Dec 31, 2025Short-term Debt
4.01MUSDFY2025 · Dec 31, 2025Deferred Revenue
16.20MUSDFY2025 · Dec 31, 2025Other Current Liabilities
946.00KUSDFY2025 · Dec 31, 2025Long-term Debt
75.02MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
3.26MUSDFY2025 · Dec 31, 2025Common Stock (Book)
32.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-17.30MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
13.99MUSDvs all stocks (USD)
Treasury Stock
152.62MUSDFY2025 · Dec 31, 202552-Week Low
11.01USDUpdated Jul 19, 202652-Week High
23.00USDUpdated Jul 19, 202652-Week Change
55.02%vs all stocks
Beta
0.3780xvs all stocks
50-Day MA
19.99USDUpdated Jul 19, 2026200-Day MA
17.15USDUpdated Jul 19, 2026Avg 10-Day Volume
76.04KSharesUpdated Jul 19, 2026Avg 30-Day Volume
137.57KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.3900USDUpdated Jul 19, 2026Other Income / Expense
-95.00KUSDFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Cumulative Treasury Stock Significant With Elevated ROE And FCF-To-Equity
It has bought back shares for years, and its equity earns more than its industry and yields heavy free cash flow.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 41.9%, higher than 95% of its Health Information Services peers (median 0.5%)Significant
Return on equity: 0.42Industry median: 0.01Industry P95: 0.36Peers compared: 33.00
Current ratio is 0.52×, lower than 95% of its Health Information Services peers (median 2.31×)Significant
Current ratio: 0.52Industry median: 2.31Industry P5: 0.60Peers compared: 33.00
Debt-to-equity is 5.78×, higher than 95% of its Health Information Services peers (median 0.15×)Significant
Debt-to-equity: 5.78Industry median: 0.15Industry P95: 1.91Peers compared: 33.00
Price-to-book is 36.36×, higher than 95% of its Health Information Services peers (median 2.76×)Significant
Price-to-book: 36.36Industry median: 2.76Industry P95: 23.81Peers compared: 33.00
Structural Tensions
Returns appear driven by leverageSignificant
Return on Equity: 0.42Debt-to-Equity: 5.78
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.44Dividend per Share: 0.60Earnings per Share: 0.39
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: 0.07
Financial Health
Altman Z-Score 3.68: safe zoneNotable
Altman Z-Score: 3.68
High earnings qualityNotable
Earnings Quality Score: 0.81
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Levered free cash flow is $19.73M, above the global median of $16.24MNotable
Levered free cash flow (USD): 19,732,250Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Sophia Genetics SA
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
Bairong Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceProduction
Beijing Dataway Horizon Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Computer Engineer & Consulting Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Bonree Data Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Japan Business Systems Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Xinjiang Sailing Information Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Lunit Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Business Engineering Corp.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
CI&T Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Booz Allen Hamilton Holding Corporation
6 interpretationsROE, ROA, And Operating ROA ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital ElevatedCumulative Treasury Stock Significant With Elevated ROE And FCF-To-EquityLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated
Illinois Tool Works Inc.
6 interpretationsROE, ROA, And Operating ROA ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital ElevatedCumulative Treasury Stock Significant With Elevated ROE And FCF-To-EquityLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated
Atmus Filtration Technologies Inc.
5 interpretationsROE, ROA, And Operating ROA ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital ElevatedLow Fixed-Asset Share With Elevated TurnoverThree Asset-Base Ratios Elevated